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S364 Poster Session IIlymphoma.Within the 11-mere, the peptide with the highest affinity
to an MCH allele was a 9-mere and tetrameres with the MCH allele
A2402 and the 9-mere positively stained expanded T-cells. The tet-
ramere positive T-cells were found to be CD107a-positive after
stimulation with dendritic cells pulsed with the peptide. T-cells spe-
cific for that HY minor were found after expansion in two of four
A2402 positive patient/donor pairs with female donor and male pa-
tient.
Conclusion: A new HY minor has been identified using a high-
throughput methodology suitable for identifying more HY minors
and possibly also autosomally expressed minor histocompatibility
antigens.433
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Background: Liver function abnormalities are common after hema-
topoietic stem cell transplantation (HSCT) and liver biopsy is often
used to direct treatment. We reviewed 117 consecutive liver biopsies
during the last 8 years at our institution.
Materials and Methods: From 2003 to 2010, 117 liver biopsies were
performed on patients who had undergoneHSCT for hematological
malignancies and presented with liver dysfunction. All slides were
evaluated for features of GVHD by cholestasis, fibrosis, lobular in-
flammation, iron deposition and were graded from 0 to 3 (0 5
none, 1 5 mild, 2 5 moderate and 3 5 severe).
Results: The median age of the patients was 49 (range 14-66). Fifty
seven (49%) patients underwent related donor (RD) and 60 (51%)
unrelated donor (URD) transplantations. Preparative regimens
were applied based on their disease; GVHD prophylaxis was tacroli-
mus and mycophenolic acid in 105 (88%) patients; tacrolimus, siro-
limus and thymoglobulin in 6 (5%), and other regiments in 6 (5%).
Fifty nine patients were alive with a median follow up for the surviv-
ing patients of 4.2 years (range 0.9-9.3 years). Kaplan-Meier estimate
of overall survival at 6 years was 43% +/- 5%. Liver biopsies were
preformed at a median of 173 days post-transplant (range 22-1366
days). At the time of the liver biopsy, the median AST was 168 IU/
L (range 18-1425 IU/L), ALT 250 IU/L (range 38-1495 IU/L), total
bilirubin 1.1 mg/dL (range 0.1-26.8 mg/dL) and alkaline phospha-
tase 278 IU/L (range 69-1547 IU/L). On biopsy there were 107
(91%) patients with histological features of GVHD: mild 29
(27%), moderate 56 (52%) or severe 22 (21%). Iron deposition stud-
ies showed 5 (4%) patients without iron deposition, 23 (20%) pa-
tients grade 1, 38 (32%) patients grade 2, and 51 (44%) patients
grade 3. In multivariate analysis of relevant prognostic factors in-
cluding age, donor, total bilirubin, ALT and histological grade of
cholestasis, only total bilirubin of\5 1.5 IU/L predicted favorable
survival (hazard ratio 5 0.34; 95% CI 0.19 - 0.63, p 5 0.001).
Conclusion: Liver biopsy confirmed the presence of GVHD in most
patients. The histological features of GVHDand iron deposition did
not adversely influence the survival. The most significant predictor
of survival was the presence of cholestasis on biopsy and the elevation
of total bilirubin of.1.5 mg/dL. Our data indicated limited value of
liver biopsy in management of patients with liver dysfunction after
allogeneic stem cell transplantation.434
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Objectives: Donor T lymphocytes play a critical role in alloim-
mune reactivities after allogeneic hematopoietic stem cell trans-
plantation (allo-HSCT). CD28, inducible co-stimulator (ICOS)
and cytotoxic T-lymphocyte antigen 4 (CTLA-4) belong to the
same family of T-cell costimulatory molecules. After activation,
three effector pathways have been described for T-cell cytotoxic-
ity: granzyme B/perforin, Fas/Fas ligand (FasL) and secreted
molecules such as TNF-alpha. Near recently, several important
polymorphisms have been identified in those genes and reported
to be associated with the risk of autoimmune diseases, malignan-
cies and allograft rejection in solid organ transplantation patients.
However, such information is less available in allo-HSCT. In the
present study, we first investigated the influence of those genes
polymorphic features on the abilities of T-cell alloimmune re-
sponses in allo-HSCT setting.
Methods: We analyzed 10 single nucleotide polymorphisms
(SNPs) in the CD28, ICOS, CTLA-4, Granzyme B, Fas and
FasL genes in 138 pairs of recipients and their unrelated donors
(URDs) and 102 pairs of recipients and their HLA-identical sib-
ling donors.
Results: (1) We found two SNPs in donors influenced the risk of
aGVHD. The association was particularly strong in the URD trans-
plantation cohort. Unrelated donor with Granzyme B +55 mutated
genotype (AA) was an independent risk factor for grades II-IV
aGVHD (P5 0.024, RR5 1.811, 95%CI, 1.080-3.038). While un-
related donor with CTLA-4 CT60 mutated genotype (AA) was pro-
tective (P 5 0.025, RR 5 3.806, 95%CI, 1.187-12.204). (2)
However, donor with CTLA-4 CT60 AA genotype was a risk of
early CMV infection (P \ 0.0001, RR 5 0.383, 95%CI, 0.243-
0.605) and relapse after allo-HSCT in AML patients (P 5 0.047,
RR 5 2.792 95%CI, 1.013-7.696). Furthermore, AML patients
with Fas -670 homogeneous mutated allele (TT genotype) also
had a higher risk of relapse (P 5 0.003, RR 5 3.823 95%CI,
1.566-9.337). (3) The presence of those susceptible alleles in donor
and/ or recipient (patients receiving CTLA-4 CT60 AA donor, pa-
tients receiving GranzymeB +55 AA donor, AML patients with Fas
-670 TT genotype or with all) resulted in a reduced overall survival
compared with those with wild-type genotypes (54.9% vs 69.5%,
P 5 0.029).
Conclusions:The results of this study highlight the important effect
of genetic variations in T-cell activation and effector pathways from
the donors and recipients on the outcomes of allo-HSCT.435
SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE IS ASSOCIATED WITH
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Allogeneic hematopoietic stem cell transplantation (AHSCT) is
a curative therapy for hematologic malignancies. Chronic GVHD
(cGVHD) is a significant barrier to successful AHSCT. Although
T cells have been implicated in cGVHD pathobiology, the role
of the thymus in this process has yet to be clearly defined. We
characterized thymus and spleen T cell subsets in a murine
model of cGVHD (B10.D2/BALB/c) to investigate the role
of the thymus in this process. Once cGVHD was well-estab-
lished, 4-6 weeks post AHSCT, total thymocyte numbers in
mice with cGVHD were more than 20-fold depleted compared
to syngeneic controls. Furthermore, the double positive thymo-
cyte cell population (CD4+ CD8+) was most markedly reduced,
with a 90-fold reduction in numbers compared to syngeneic con-
trols. Despite evidence of thymic atrophy and diminished thymo-
poiesis, thymic CD4+ single positive cells were decreased less
proportionally (13-fold). Congenic AHSCT demonstrated that
this CD4+ population was comprised of donor peripherally de-
rived CD44hi memory T cells, representing an allogeneic infil-
trate. Further evidence of diminished thymic output was found
in the periphery. Live splenocytes were 3-fold depleted in
